Lea Eslava-Kim, PharmD, Author at MPR

Lea Eslava-Kim, PharmD

Lea Eslava-Kim, PharmD, is a Drug Information Specialist for MPR. She received her doctorate in pharmacy from the Ernest Mario School of Pharmacy, Rutgers University and completed her pharmacy residency at Clara Maass Medical Center. She is a licensed pharmacist.

All articles by Lea Eslava-Kim, PharmD

Tivicay PD Approved for Pediatric HIV Patients

The FDA has approved Tivicay PD (dolutegravir; Viiv Healthcare) tablets for oral suspension, for the treatment of HIV-1 infection in treatment-naïve or -experienced but integrase inhibitor-naïve pediatric patients aged ≥4 weeks and weighing at least 3kg, in combination with other antiretroviral agents.